Cargando…
rhEGF Treatment Improves EGFR Inhibitor-Induced Skin Barrier and Immune Defects
SIMPLE SUMMARY: In our prior study, we demonstrated that recombinant human epidermal growth factor (rhEGF) treatment is effective for managing epidermal growth factor receptor inhibitors (EGFRIs)-related skin toxicities and improves patients’ quality of life (QoL) compared with placebo. Nevertheless...
Autores principales: | Kim, Ji Min, Ji, Jun Ho, Kim, Young Saing, Lee, Suee, Oh, Sung Yong, Huh, Seok Jae, Son, Choon Hee, Kang, Jung Hun, Ahn, So Yun, Choo, Jung Eun, Song, Ki-Hoon, Roh, Mee Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692663/ https://www.ncbi.nlm.nih.gov/pubmed/33113881 http://dx.doi.org/10.3390/cancers12113120 |
Ejemplares similares
-
Potential protective effects of rhEGF against ultraviolet A irradiation-induced damages on human fibroblasts
por: Kim, Ji Min, et al.
Publicado: (2018) -
Enhancement of Skin Wound Healing by rhEGF-Loaded Carboxymethyl Chitosan Nanoparticles
por: Zhang, Pei, et al.
Publicado: (2020) -
rhEGF-Loaded Hydrogel in the Treatment of Chronic Wounds in Patients with Diabetes: Clinical Cases
por: de Oliveira, Beatriz Guitton Renaud Baptista, et al.
Publicado: (2022) -
Immuno-modulatory effect of local rhEGF treatment during tissue repair in diabetic ulcers
por: García-Honduvilla, Natalio, et al.
Publicado: (2018) -
Responsive Cells for rhEGF bioassay Obtained through Screening of a CRISPR/Cas9 Library
por: Qin, Xi, et al.
Publicado: (2019)